Neurorehabilitation may evolve through a deeper understanding of neuroplasticity, the brain’s adaptability, which drives innovative interventions. Multi-center adaptive clinical trials offer a dynamic platform to evaluate interventions globally with real-time implementation of the currently best performing therapy. Bridging basic neuroscience with clinical practice offers the potential for targeted therapies that optimize recovery mechanisms. Personalized medicine provides possibilities of developing interventions based on genetic, biological, and psychosocial factors, while wearable technologies expand therapy beyond clinical settings. Challenges include demographic shifts and resource constraints, which require equitable access to sustainable funding. Collaboration among stakeholders is crucial for accelerating evidence-based practice and has the potential to revolutionize neurorehabilitation. By employing adaptive trials, integrating neuroscience, and utilizing wearable technology, the future of neurorehabilitation holds the potential to significantly enhance recovery for neurological populations worldwide.